Pfizer (NYSE:PFE) shares slid about 1% Tuesday morning after reports that a patient died while receiving the company's hemophilia drug Hympavzi, highlighting challenges in blood disorder treatments.

Many families of children with autism are worried that the life-changing services their kids receive will no longer be ...

WITH thousands of girls continuing to give birth every year, the Department of Social Welfare and Development (DSWD) is pushing for the nationwide implementation of its ProtecTEEN Program, a social ...

Investing.com -- A patient died after receiving Pfizer Inc.’s (NYSE:PFE) hemophilia drug Hympavzi, adding to challenges for the company in blood disorder treatments.

Global digital asset trading platform KAI Exchange has officially unveiled its brand positioning and core technical architecture. The platform also announ ...

MinIO, the data foundation for enterprise AI, today announced new subscription tiers for MinIO AIStor: AIStor Free and AIStor Enterprise Lite. These new tiers join the existing AIStor Enterprise ...

T3's Technology Conference for financial professionals, which is widely known as the wealth management industry's most established and trusted technology event, will debut T3 AI University at its 2026 ...

The Electric solar wind Sail doctors (E-Sailors) is a challenge-based Doctoral Network that aims to bring Electric solar wind sail (E-sail) from low Earth orbit (LEO) demonstration missions to the ...